WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007010954) THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/010954    International Application No.:    PCT/JP2006/314317
Publication Date: 25.01.2007 International Filing Date: 13.07.2006
IPC:
C07D 333/32 (2006.01), C07D 409/12 (2006.01)
Applicants: NISSAN CHEMICAL INDUSTRIES, LTD. [JP/JP]; 7-1, Kanda-Nishiki-cho 3-chome, Chiyoda-ku, Tokyo, 1010054 (JP) (For All Designated States Except US).
MIYAJI, Katsuaki [JP/JP]; (JP) (For US Only).
YANAGIHARA, Kazufumi [JP/JP]; (JP) (For US Only).
SHIGETA, Yukihiro [JP/JP]; (JP) (For US Only).
IWAMOTO, Shunsuke [JP/JP]; (JP) (For US Only).
HORIKAWA, Masato [JP/JP]; (JP) (For US Only).
HIROKAWA, Yutaka [JP/JP]; (JP) (For US Only).
OWADA, Shingo [JP/JP]; (JP) (For US Only).
NAKANO, Satoshi [JP/JP]; (JP) (For US Only).
OTA, Hirofumi [JP/JP]; (JP) (For US Only).
ISHIWATA, Norihisa [JP/JP]; (JP) (For US Only)
Inventors: MIYAJI, Katsuaki; (JP).
YANAGIHARA, Kazufumi; (JP).
SHIGETA, Yukihiro; (JP).
IWAMOTO, Shunsuke; (JP).
HORIKAWA, Masato; (JP).
HIROKAWA, Yutaka; (JP).
OWADA, Shingo; (JP).
NAKANO, Satoshi; (JP).
OTA, Hirofumi; (JP).
ISHIWATA, Norihisa; (JP)
Agent: SENMYO, Kenji; 4th Floor, SIA Kanda Square, 17, Kanda-konyacho, Chiyoda-ku, Tokyo 1010035 (JP)
Priority Data:
2005-206822 15.07.2005 JP
2005-206823 15.07.2005 JP
2006-083770 24.03.2006 JP
2006-083771 24.03.2006 JP
2006-115569 19.04.2006 JP
Title (EN) THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS
(FR) COMPOSES THIOPHENES ET ACTIVATEURS DU RECEPTEUR THROMBOPOIETINE
Abstract: front page image
(EN)ABSTRACT A compound represented by the formula (I) (wherein R¿1?, R¿2?, R¿3? and R¿4? are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
(FR)L'invention concerne un composé représenté par la formule (I) (où R1, R2, R3 et R4 sont tels que définis dans la description), un tautomère, un promédicament, ou un sel pharmaceutiquement acceptable de ce composé, ou un solvate de celui-ci.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)